| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.13▼ | 3.15▼ | 3.15▼ | 3.38▼ | 3.64▼ |
| MA10 | 3.16▼ | 3.19▼ | 3.21▼ | 3.52▼ | 3.93▼ |
| MA20 | 3.22▼ | 3.32▼ | 3.35▼ | 3.78▼ | 5.38▼ |
| MA50 | 3.40▼ | 3.54▼ | 3.60▼ | 4.30▼ | 7.12▼ |
| MA100 | 3.61▼ | 3.72▼ | 3.70▼ | 5.63▼ | 42.86▼ |
| MA200 | 3.67▼ | 5.11▼ | 5.28▼ | 6.90▼ | 122.78▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.012▼ | -0.015▼ | -0.019▼ | -0.021▼ |
| RSI | 34.965▼ | 35.225▼ | 35.530▼ | 30.817▼ | 36.209▼ |
| STOCH | 42.235 | 21.993 | 14.658▼ | 17.554▼ | 16.418▼ |
| WILL %R | -83.871▼ | -95.495▼ | -95.495▼ | -93.496▼ | -95.599▼ |
| CCI | -67.977 | -81.988 | -87.465 | -165.684▼ | -80.097 |
|
Tuesday, August 12, 2025 07:49 PM
Lyra Therapeutics develops bioabsorbable implant devices designed to treat chronic rhinosinusitis, an inflammatory nasal condition affecting millions of people. Its lead product candidate, LYR-210, is ...
|
|
Friday, June 27, 2025 09:52 AM
(RTTNews) - Lyra Therapeutics Inc. (LYRA) announced Friday a registered direct offering of 423,372 shares of common stock (or pre-funded warrants) priced at-the-market under Nasdaq rules, along with a ...
|
|
Monday, June 02, 2025 04:14 AM
Lyra's LYR-210 showed significant symptom improvement in CRS patients in the ENLIGHTEN 2 trial, meeting primary and secondary endpoints. Lyra Therapeutics announced positive results from their ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/12/25 | 3.19 | 3.19 | 3.095 | 3.10 | 8,024 |
| 30/12/25 | 3.31 | 3.3317 | 3.02 | 3.20 | 52,314 |
| 29/12/25 | 3.59 | 3.59 | 3.27 | 3.41 | 48,870 |
| 26/12/25 | 3.64 | 3.70 | 3.19 | 3.59 | 32,339 |
| 24/12/25 | 3.66 | 3.66 | 3.52 | 3.58 | 3,966 |
| 23/12/25 | 3.66 | 3.66 | 3.51 | 3.56 | 7,282 |
| 22/12/25 | 3.63 | 3.7436 | 3.60 | 3.62 | 23,939 |
| 19/12/25 | 3.935 | 4.04 | 3.56 | 3.60 | 42,041 |
| 18/12/25 | 3.87 | 3.87 | 3.6675 | 3.72 | 15,076 |
| 17/12/25 | 4.005 | 4.005 | 3.75 | 3.84 | 16,742 |
|
|
||||
|
|
||||
|
|